{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:11:37Z","timestamp":1791425497896,"version":"4.3.3"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T00:00:00Z","timestamp":1392595200000},"content-version":"vor","delay-in-days":3487,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/j.joca.2004.04.010","type":"journal-article","created":{"date-parts":[[2004,6,25]],"date-time":"2004-06-25T08:32:08Z","timestamp":1088152328000},"page":"642-649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee"],"prefix":"10.1016","volume":"12","author":[{"given":"Roy D.","family":"Altman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"\u00c5kermark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 D.","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schnitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2004.04.010_BIB1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.2105\/AJPH.74.6.574","article-title":"Epidemiology of musculoskeletal impairments and associated disability","volume":"74","author":"Cunningham","year":"1984","journal-title":"Am J Public Health"},{"issue":"Suppl 1","key":"10.1016\/j.joca.2004.04.010_BIB2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/41.S1.3","article-title":"The prevalence and burden of arthritis","volume":"41","author":"Reginster","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.joca.2004.04.010_BIB3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bmj.286.6363.418","article-title":"The nature and causes of osteoarthrosis","volume":"286","author":"Gardner","year":"1983","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.joca.2004.04.010_BIB4","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0002-9343(86)90075-6","article-title":"Pathogenesis of osteoarthritis","volume":"80","author":"Howell","year":"1986","journal-title":"Am J Med"},{"key":"10.1016\/j.joca.2004.04.010_BIB5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/art.1780260712","article-title":"Social and economic impacts of four musculoskeletal conditions. A study using national community-based data","volume":"26","author":"Kramer","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2004.04.010_BIB6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/03009748209096891","article-title":"Epidemiological aspects of osteoarthritis\u2014an interview survey of the Swedish population and a review of previous studies","volume":"43","author":"Bjelle","year":"1982","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.joca.2004.04.010_BIB7","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/ard.55.8.552","article-title":"Recommendations for the registration of drugs used in the treatment of osteoarthritis. Group for the respect of ethics and excellence in science (GREES): osteoarthritis section","volume":"55","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2004.04.010_BIB8","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/art.1780381104","article-title":"Guidelines for the medical management of osteoarthritis: part II: osteoarthritis of the knee","volume":"38","author":"Hochberg","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2004.04.010_BIB9","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/1529-0131(200108)44:8<1800::AID-ART317>3.0.CO;2-1","article-title":"Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement","volume":"44","author":"Lisignoli","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"Suppl 39","key":"10.1016\/j.joca.2004.04.010_BIB10","first-page":"3","article-title":"Viscosupplementation: a new concept in the treatment of osteoarthritis","volume":"20","author":"Balazs","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2004.04.010_BIB11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2165\/00003495-199447030-00009","article-title":"Hyaluronic acid. A review of its pharmacology and use as a surgical aid in ophthalmology, and its therapeutic potential in joint disease and wound healing","volume":"47","author":"Goa","year":"1994","journal-title":"Drugs"},{"issue":"Suppl 39","key":"10.1016\/j.joca.2004.04.010_BIB12","first-page":"10","article-title":"Intrarticular hyaluronan injections in the treatment of osteoarthritis: state of the art review","volume":"20","author":"Peyron","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2004.04.010_BIB13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00003495-199600523-00006","article-title":"Current pharmacological treatment of osteoarthritis","volume":"52","author":"Wollheim","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.joca.2004.04.010_BIB14","first-page":"2203","article-title":"Intra-articular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial","volume":"25","author":"Altman","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2004.04.010_BIB15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2165\/00044011-200222030-00002","article-title":"Non-animal stabilised hyaluronic acid in the treatment of osteoarthritis of the knee\u2014a tolerability study","volume":"22","author":"\u00c5kermark","year":"2002","journal-title":"Clin Drug Invest"},{"issue":"Suppl 39","key":"10.1016\/j.joca.2004.04.010_BIB16","first-page":"16","article-title":"An analysis of clinical studies of the use of cross-linked hyaluronan, hylan, in the treatment of osteoarthritis","volume":"20","author":"Adams","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2004.04.010_BIB17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2004.04.010_BIB18","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/joca.2000.0361","article-title":"Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative","volume":"8","author":"Dougados","year":"2000","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2004.04.010_BIB19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2165\/00003088-200241080-00004","article-title":"Elimination of stabilised hyaluronan from the knee joint in healthy men","volume":"41","author":"Lindqvist","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.joca.2004.04.010_BIB20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1063-4584(05)80013-5","article-title":"The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone","volume":"3","author":"Adams","year":"1995","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2004.04.010_BIB21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0950-3579(97)80009-X","article-title":"Intra-articular therapy in osteoarthritis","volume":"11","author":"Kirwan","year":"1997","journal-title":"Baillieres Clin Rheumatol"},{"key":"10.1016\/j.joca.2004.04.010_BIB22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0169-409X(91)90004-V","article-title":"Turnover of hyaluronan in the tissues","volume":"7","author":"Laurent","year":"1991","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.joca.2004.04.010_BIB23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1136\/ard.32.2.103","article-title":"Distribution of biologically labelled radioactive hyaluronic acid injected into the joints","volume":"32","author":"Antonas","year":"1973","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2004.04.010_BIB24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0934-8832(11)80054-5","article-title":"Catabolism of hyaluronan in the knee joint of the rabbit","volume":"12","author":"Laurent","year":"1992","journal-title":"Matrix"},{"key":"10.1016\/j.joca.2004.04.010_BIB25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1113\/expphysiol.1991.sp003474","article-title":"Turnover of hyaluronan in synovial joints: elimination of labelled hyaluronan from the knee joint of rabbit","volume":"76","author":"Brown","year":"1991","journal-title":"Exp Physiol"},{"key":"10.1016\/j.joca.2004.04.010_BIB26","first-page":"355","article-title":"Elimination of tritium-labelled hyaluronic acid from normal and osteoarthritic rabbit knee joints","volume":"35","author":"Lindenhayn","year":"1997","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.joca.2004.04.010_BIB28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1651-2227.1999.tb01320.x","article-title":"Endoscopic treatment of children of vesico-ureteric reflux","volume":"88","author":"Lackgren","year":"1999","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.joca.2004.04.010_BIB29","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2106\/00004623-200209000-00015","article-title":"Increased frequency of acute local reaction to intra-articulr hyaln GF-20 (synvisc) in patients receiving more than one course of treatment","volume":"84A","author":"Leopold","year":"2002","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.joca.2004.04.010_BIB30","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1053\/sarh.2002.50008","article-title":"Intra-articular hyaluronans: a review of product-specific safety profiles","volume":"32","author":"Hamburger","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.joca.2004.04.010_BIB31","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/01926230390204360","article-title":"Hylan G-F 20 induces delayed foreign body inflammation in guinea pige and rabbits","volume":"31","author":"Sasaki","year":"2003","journal-title":"Toxicol Pathol"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458404000858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458404000858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:04:17Z","timestamp":1761015857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458404000858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S1063458404000858"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2004.04.010","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of a single intra-articular injection of non-animal stabilized hyaluronic acid (NASHA) in patients with osteoarthritis of the knee","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2004.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}